Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety, Tolerability, and Drug Levels of MYK-224 Administered in Single and Multiple Doses in Healthy Adult Japanese Participants
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety in Transfusion Independent Non-severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Drug Levels of CC-92480 After Coadministration With Rifampin and Itraconazole, and the Drug Levels of Digoxin and Rosuvastatin After Coadministration With CC-92480 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis
- Status
- TERMINATED
- Phase
- N/A
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
- Status
- RECRUITING
- Phase
- NA
SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice
- Status
- TERMINATED
- Phase
- PHASE4
A Study to Evaluate the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Drug Exposure of Single Ascending Doses of BMS-986369 and the Effect of Food on the BMS-986369 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Drug Levels of Cendakimab Delivered Subcutaneously in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Abatacept in Immune Checkpoint Inhibitor Myocarditis
- Status
- RECRUITING
- Phase
- PHASE3
A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for Participants With Relapsing-remitting Multiple Sclerosis Treated With Ozanimod (Zeposia®)
- Status
- COMPLETED
- Phase
- N/A
A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
- Status
- RECRUITING
- Phase
- N/A
A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)
- Status
- COMPLETED
- Phase
- N/A